As in vitro diagnostic (IVD) markets and regulations change, it’s imperative to stay up-to-date on clinical trial components that are required to facilitate efficient, cost-effective market approvals. During this NAMSA-sponsored webinar, Kristin Jones, MS, CCRA (Principal Medical Research Manager), will discuss the essential mechanisms that must be addressed throughout IVD clinical studies regardless of product type or intended market launch territory.
Highlighted will be:
Time will also be allotted for Q&A.
About the Presenter:
Kristin Jones, MS, CCRA; Principal Medical Research Manager – IVD; NAMSA
Kristin has over 20 years’ experience using IVD instruments in a lab setting, managing studies and clinical research teams, as well as assisting with regulatory and quality concerns. She’s brought several products from concept to commercialization, including automated assay platforms for use in several therapeutic areas. Her expertise spans the globe as she’s helped to launch products in the U.S., Canada, Europe and China. Prior to NAMSA, Kristin spent 18 years at Beckman Coulter where she held numerous positions including Clinical Studies Scientist, Senior Clinical Studies Scientist, Staff Clinical Studies Scientist and Manager of Clinical Affairs.
Want to learn more about NAMSA’s IVD development solutions? Please visit the links below:
*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed and stored by NAMSA to better understand your product needs and interests.